Samakind
by Mankind Pharma · DCGI approved 2025
| Active ingredient | Semaglutide (GLP-1 receptor agonist) |
| Indication | Multiple Indications |
| Manufacturer | Mankind Pharma Ltd |
| DCGI status | Approved 2025 |
| Price (MRP) | TBC (price band to be announced) |
| Format | Prefilled pen |
| Prescription | Schedule H — required |
How Samakind compares
Samakind is Mankind Pharma's brand of generic semaglutide. Mankind's strategic differentiator is the deepest pharmaceutical distribution into India's Tier-2 and Tier-3 cities — Samakind is positioned to be one of the first semaglutide brands to meaningfully reach patients beyond metro India. Final price band has not yet been published.
About Mankind Pharma
Mankind Pharma is India's third-largest pharmaceutical company by domestic sales and one of the few with a deeper distribution network than Sun Pharma in non-metro India. Mankind's affordable-pricing track record across cardiac, gastro, and diabetic segments suggests Samakind will be priced competitively.
GLP-1 Check is informational, not a medical diagnosis. Semaglutide is a Schedule H drug in India and requires a prescription from a registered medical practitioner. Always consult a qualified physician before starting any treatment.